國家衛生研究院 NHRI:Item 3990099045/1134
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 915448      Online Users : 1249
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/1134


    Title: Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones
    Authors: Chern, JH;Lee, CC;Chang, CS;Lee, YC;Tai, CL;Lin, YT;Shia, KS;Lee, CY;Shih, SR
    Contributors: Division of Biotechnology and Pharmaceutical Research
    Abstract: A series of novel, oxime ether-containing pyridyl imidazolidinones were synthesized and their antiviral activity was evaluated in a plaque reduction assay. It is very interesting that this class of compounds is specific for human enteroviruses, in particular, enterovirus 71 (EV71). Some derivatives strongly inhibited enterovirus replication with activities higher or comparable to those of the reference compounds such as A(1) and A(2). Preliminary SAR studies revealed that the chain length of the alkyl linker and the alkyl substituent at the oxime ether group largely influenced the in vitro anti-EV71 activity of this new class of potent antiviral agents. Among this series of compounds synthesized, the pyridyl imidazolidinone with an ethyl oxime ether group located at the para position of the phenoxyl ring (8b) was identified as the most potent enterovirus 71 inhibitor (IC50 = 0-001 muM) with no apparent cytotoxic effect toward RD (rhabdomyosarcoma) cell lines (CC50 > 25 muM). Furthermore, this compound has been shown broad-spectrum activity against most of the serotypes of enteroviruses tested in the nanomolar range. (C) 2004 Elsevier Ltd. All rights reserved.
    Keywords: Chemistry, Medicinal;Chemistry, Organic
    Date: 2004-10-18
    Relation: Bioorganic and Medicinal Chemistry Letters. 2004 Oct;14(20):5051-5056.
    Link to: http://dx.doi.org/10.1016/j.bmcl.2004.07.084
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0960-894X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000224165900005
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=4544319944
    Appears in Collections:[Kak-Shan Shia] Periodical Articles
    [Jyh-Haur Chern] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    000224165900005.pdf286KbAdobe PDF993View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback